With recent increases in legal and social acceptance of transgender individuals, and as many as 1 to 1.4 million transgender adults living in the United States,[1]
[2] there has been a growing demand for gender-affirming medical procedures, including genital affirmation surgeries.[3] Genital affirmation options for transgender men include metoidioplasty and phalloplasty, often with urethral lengthening, scrotoplasty, and testicular implants. The most commonly described option in the literature is phalloplasty performed with the radial forearm flap, but other phalloplasty options include the free or pedicled anterolateral thigh (ALT) flap, the pedicled suprapubic abdominal wall flap, and the fibular free flap.[4] Such procedures can be completed in up to four planned stages, although unplanned surgical interventions are sometimes required during follow-up care.
In recent years, several reviews on masculinizing genital affirmation surgery have described various surgical techniques and examined both outcomes and complication rates associated with these procedures.[4]
[5]
[6]
[7]
[8]
[9] Overall, the rate of urethral complications exceeds 30% for masculinizing genital affirmation surgeries.[8] The most common complications of such procedures are generally related to urethral lengthening (urethroplasty), with urethral strictures and urethrocutaneous fistulae being the most commonly reported complications.[10] Additionally, complete flap loss presents as one of the most concerning complications related to gender-affirming phalloplasty. Some studies have suggested that the high rate of complications may be a result of several different factors, including flap type and number of stages.[11]
[12]
[13] However, rates of reported complications vary widely between studies and procedures, even when examining rates by flap type, making it challenging to identify a single surgical technique as the gold standard for masculinizing gender surgery without additional evidence.[4]
[8]
[14] To address this dearth, this systematic review investigates the question: do flap type and number of surgical stages affect complication rates of phalloplasty procedures performed in transgender men?
Methods
Preferred Reporting Items for Systematic Reviews and Meta-Analyses[15] guidelines were used to develop the protocol for this systematic review, as reported in [Fig. 1]. Online database searches were conducted using PubMed, Embase, Web of Science, and Cochrane Central Register of Controlled Trials. Additional hand searches through the journals of Plastic and Reconstructive Surgery, Journal of Sexual Medicine, and the International Journal of Transgender Health (formerly known as the International Journal of Transgenderism) were completed. All searches were conducted from inception through February 2019. Searches were conducted in consultation with a research librarian using a combination of the terms “phalloplasty,” “metoidioplasty,” “transgender men,” “gender affirming surgery,” “sex reassignment surgery,” “gender dysphoria,” “female to male,” “genital affirmation,” “urethroplasty,” “urethral lengthening,” and “neophallus.” A full search term strategy is available through the PROSPERO registry in protocol 158722.
Fig. 1 Flow diagram for literature search according to Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines.
Inclusion criteria required articles to be full-text articles about transgender men who have undergone genital affirmation surgery, written in English, and include patient- or physician-reported outcomes. Following the removal of duplicate records, a title and abstract search was performed to include only papers on primary phalloplasty performed on transgender men. A full review of all remaining articles was then completed. Studies were excluded from the final analysis if they did not differentiate between cisgender and transgender men, reported phalloplasty for reasons other than gender affirmation, did not include outcome measurements, reported results of revision procedures, reported metoidioplasty, or were not full-text articles. A full review of all articles was then completed.
Data were independently extracted regarding sample demographics, sample size, sampling methods, cohort inclusion and exclusion, study type, institutional review board (IRB) approval, surgical flap type, facility type, type of surgeon, surgical stages, urethral reconstruction technique, follow-up care, surgical complications, and surgical restrictions. The total number of patients experiencing each complication was extracted from the article texts and proportions were then calculated using the total sample size. Data were stratified by number of stages and phallus flap type for each study. Each study was also evaluated for its level of evidence using Grading of Recommendations, Assessment, Development and Evaluations (GRADE) guidelines.[16] Bias was assessed through the Murad et al tool for assessing case series as no study contained a control group.[17] Extracted data were tabulated into systematic review tables both quantitatively and qualitatively summarizing the evidence wherever possible. All screening, data extraction, and analyses were completed by a minimum of two authors to prevent bias. Any conflicts following screening and data extraction were resolved through review by a third author.
Results
Following the removal of duplicate records, our search strategy yielded 4,374 unique articles that were screened for inclusion by the authors. Ninety-one full-text articles were screened following a title and abstract screening. Using the aforementioned inclusion criteria, 25 full-text articles were included for analysis.[13]
[18]
[19]
[20]
[21]
[22]
[23]
[24]
[25]
[26]
[27]
[28]
[29]
[30]
[31]
[32]
[33]
[34]
[35]
[36]
[37]
[38]
[39]
[40]
[41] A full flow diagram with all screening and exclusion decisions is available in [Fig. 1].
A total of 1,674 transgender men seeking phalloplasty as part of gender affirmation surgery, and who had not had prior metoidioplasty or phalloplasty, were identified across all included studies ([Table 1]). Ages ranged widely, with reported ages between 19 years old and the 60s (not specified), with most mean ages falling between 27 and 37 years. Follow-up times ranged from 1 to 270 months. The GRADE quality of evidence for all included studies ranged from very low to low. Risk of bias ranged from low to high, with the majority of studies at moderate to high risk of bias. A statement confirming IRB approval was reported in two studies.[13]
[31]
Table 1
Summary of included studies sorted by type of procedure
Authors
|
Year
|
Sample size
|
Age
|
Follow-up time (mo)
|
IRB approval statement
|
Risk of individual bias (Murad et al)
|
Ascha et al
|
2018
|
213
|
ALT: 36.2 ± 9.7; RFFF: 36.7 ± 11.5
|
6
|
Included
|
Moderate; due to short follow-up time and lack of detail
|
Bettocchi et al
|
2005
|
85
|
34.4 (19–54)
|
−
|
−
|
High; due to no follow-up times provided
|
Dabernig et al
|
2006
|
5
|
30 (24–37)
|
25 (18–30)
|
−
|
High; due to small, nonrepresentative samples
|
Edgerton et al
|
1984
|
1
|
36
|
30
|
−
|
High; due to small, nonrepresentative sample
|
Fang et al
|
1999
|
22
|
−
|
−
|
−
|
High; due to small samples and no follow-up times provided
|
Fang et al
|
1994
|
56
|
−
|
−
|
−
|
High; due to small samples and no follow-up times provided
|
Garaffa et al
|
2010
|
115
|
20–55
|
26 (1–270)
|
−
|
Low
|
Hage et al
|
1993
|
25
|
33 (21–54)
|
34 (7–60 + )
|
−
|
Moderate; due to small samples
|
Kim et al
|
2010
|
70
|
34.6 (19–45)
|
54
|
−
|
Moderate; due to lack of comprehensive outcomes information
|
Krueger et al
|
2007
|
253
|
−
|
−
|
−
|
High; due to no provided follow-up time
|
Leriche et al
|
2008
|
56
|
30 (20–44)
|
110
|
−
|
Low
|
Lin and Chen
|
2009
|
1
|
24
|
18
|
−
|
High; due to small, nonrepresentative sample
|
Massie et al
|
2017
|
224
|
VC: 37 ± 11; No VC: 35 ± 7
|
VC: 21.4 ± 10.3; No VC: 17.0 ± 8.1
|
−
|
Moderate; due to lack of staging information
|
Medina et al
|
2018
|
6
|
29 (21–47)
|
−
|
Included
|
High; due to small, nonrepresentative sample
|
Monstrey et al
|
2009
|
287
|
−
|
−
|
−
|
High; due to no follow-up times provided
|
Namba et al
|
2019
|
15
|
25–43
|
6
|
Included
|
High; due to small sample and short follow-up time
|
Papadopulos et al
|
2008
|
32
|
22.1–51.5
|
12
|
−
|
Moderate; due to small sample
|
Rohrmann and Jakse
|
2003
|
25
|
33 (23–42)
|
−
|
−
|
High; due to small sample and no follow-up time provided
|
Salgado et al
|
2016
|
15
|
20s–60s
|
14.1 (2.5–25.1)
|
−
|
Moderate; due to small sample
|
Santanelli and Scuderi
|
2000
|
5
|
34.5
|
36–84
|
−
|
Moderate; due to small sample
|
Schaff
|
2007
|
66
|
−
|
14 (8–28)
|
−
|
High; due to lack of sample characteristics and differentiation between outcomes for different pars fixa techniques
|
Schaff and Papadopulos
|
2009
|
37
|
−
|
14 (9–26)
|
−
|
High; due to small sample with no information about how patients were selected
|
Song et al
|
2011
|
19
|
−
|
12–120
|
−
|
Moderate; due to small sample
|
van der Sluis et al
|
2016
|
19
|
21–57
|
35 (3–95)
|
−
|
Moderate; due to small sample
|
Zhang et al
|
2015
|
22
|
27.8 (19–34)
|
25.4 ± 6
|
−
|
Moderate; due to small sample
|
Abbreviations: ALT, anterolateral thigh; IRB, institutional review board; RFF, radial forearm flap.
Reporting of all assessed criteria varied widely across the identified papers. Sample size, patient age, follow-up time, flap types, number of stages, and rates of urethral fistulae and strictures were reported across most studies. Parameters that were rarely reported across studies included sample demographics, insurance status of patients, type of facility surgeries were performed in, types and number of surgeons involved, number of procedures per surgical encounter, number of surgical admissions, and restrictions for surgery.
Surgical Techniques: Flap Choice and Number of Stages
RFF was the most commonly reported flap choice, representing 64% of identified cases[13]
[22]
[23]
[24]
[26]
[27]
[28]
[30]
[31]
[32]
[35]
[36]
[37]
[39]
[40] ([Table 2]). Other commonly used flap types were ALT,[13]
[18]
[30]
[41] abdominal,[19]
[21]
[25]
[41] and fibular flaps.[20]
[34]
[35]
[39] Less commonly used flap types were free thoracodorsal artery perforator,[29] tensor fasciae latae island,[38] and combinations of flap types.[33] Within the identified flap types, there was substantial variation in flap subtype of the RFF, including the fasciocutaneous,[28] sensate free,[22]
[35]
[39] free radial artery forearm flap,[13]
[24]
[27]
[30]
[31]
[32]
[36]
[40] and osteocutaneous free RFF.[23]
[26]
[37]
Table 2
Surgical techniques associated with each study, sorted by flap type used
Authors
|
Year
|
Sample size
|
Phallus flap subtype
|
No. of stages
|
Pars fixa flap
|
Pars pendulans flap
|
Prelamination graft site
|
Reinforcement graft
|
Radial forearm flap (RFF)
|
Ascha et al
|
2018
|
127
|
−
|
1
|
Labia minora
|
Radial forearm free
|
−
|
Vascularized bulbospongiosus muscle
|
Kim et al
|
2010
|
70
|
Osteocutaneous free
|
1
|
Labia minora and anterior vaginal wall
|
Radial forearm osteocutaneous free
|
−
|
One or two layers of soft tissue
|
Krueger et al
|
2007
|
253
|
−
|
1
|
Labia minora
|
Radial forearm
|
−
|
−
|
Monstrey et al
|
2009
|
287
|
−
|
1
|
Labia minora and anterior vaginal wall
|
Radial forearm
|
−
|
−
|
Rohrmann and Jakse
|
2003
|
25
|
−
|
1
|
Distal vaginal flap (n = 16), labia minora (n = 5), urethral plate (n = 4)
|
Radial forearm
|
−
|
−
|
Fang et al
|
1994
|
56
|
Sensate free
|
2
|
Vestibular skin with labia minora
|
Radial forearm sensate free
|
Tubed vaginal mucosa (n = 28)
|
−
|
Leriche et al
|
2008
|
56
|
Fasciocutaneous
|
2
|
Anterior vaginal wall
|
Radial forearm fasciocutaneous
|
−
|
−
|
Medina et al
|
2018
|
6
|
−
|
2
|
Anterior vaginal wall and labia minora
|
Vaginal graft
|
Posterolateral vaginal wall mucosa
|
Labia minora
|
Salgado et al
|
2016
|
15
|
−
|
2
|
Anterior vaginal wall and labia minora
|
Radial forearm osteocutaneous free
|
Buccal mucosa and thigh skin (n = 8), vaginal mucosa only (n = 2), buccal mucosa, vaginal mucosa, and abdominal skin (n = 2), thigh skin only (n = 1), uterine and vaginal mucosa (n = 1)
|
Pedicled myofascial gracilis flap (n = 4)
|
Song et al
|
2011
|
19
|
−
|
2
|
Vestibular skin with labia minora
|
Radial forearm
|
Lower abdominal wall
|
Perineal muscle flap
|
Fang et al
|
1999
|
22
|
Osteocutaneous free
|
3
|
Vaginal flap
|
Vaginal flap
|
Vaginal mucosa
|
−
|
Schaff
|
2007
|
25
|
Sensate free
|
3
|
Vaginal flap, labia minora, or metoidioplasty
|
Radial forearm sensate free
|
Vaginal epithelium or full-thickness skin graft (n = 29, n not stratified between RFF and fibula cases)
|
−
|
Schaff and Papadopulos
|
2009
|
6
|
Sensate free
|
3
|
Anterior vaginal flap
|
Radial forearm sensate free
|
Vaginal mucosa
|
−
|
Garaffa et al
|
2010
|
115
|
Radial artery free
|
4
|
Labia minora and anterior vaginal wall
|
Radial forearm
|
−
|
Martius fat flap
|
Massie et al
|
2017
|
155
|
|
−
|
Labia minora
|
Radial forearm
|
−
|
Fasciolipomatous tissue
|
Anterolateral thigh flap
|
van der Sluis et al
|
2016
|
19
|
Pedicled
|
1
|
Infundibular tissue between labia minora
|
Radial forearm free
|
−
|
−
|
Ascha et al
|
2018
|
59
|
Pedicled
|
1
|
Labia minora
|
Pedicled anterolateral thigh
|
−
|
Vascularized bulbospongiosus muscle
|
Zhang et al
|
2015
|
8
|
Pedicled
|
2
|
Pedicled vaginal mucosa
|
Pedicled anterolateral thigh
|
Vaginal mucosa
|
−
|
Massie et al
|
2017
|
67
|
Pedicled
|
−
|
Labia minora
|
Pedicled anterolateral thigh
|
−
|
Fasciolipomatous tissue
|
Abdominal flap
|
Bettocchi et al
|
2005
|
32
|
Suprapubic
|
1
|
Clitoral and labia majora skin
|
Labia majora skin
|
−
|
−
|
Bettocchi et al
|
2005
|
33
|
Suprapubic
|
2
|
Clitoral and labia majora skin
|
Labia majora skin
|
−
|
Martius fat pad
|
Edgerton et al
|
1984
|
1
|
Midline bipedicle
|
2
|
Pedicled bladder
|
Pedicled bladder
|
−
|
−
|
Zhang et al
|
2015
|
14
|
−
|
2
|
Pedicled vaginal mucosa
|
Abdominal flap
|
Vaginal mucosa
|
−
|
Hage et al
|
1993
|
25
|
Abdominal skin (n = 16), rectus abdominis myocutaneous (n = 7), groin skin (n = 2)
|
3
|
Anterior vaginal wall and labia minora
|
Abdominal skin, groin skin, or rectus myocutaneous skin
|
−
|
−
|
Fibular flap
|
Dabernig et al
|
2006
|
5
|
Sensate free septocutaneous
|
2
|
Anterior vaginal flap and vestibular skin strip
|
Sensate free septocutaneous fibular flap
|
Split-thickness skin graft from left thigh
|
−
|
Papadopulos et al
|
2008
|
32
|
Sensate free osteocutaneous
|
3
|
Anterior vaginal flap
|
Sensate free osteocutaneous fibular flap
|
Split-thickness skin graft from anterior thigh
|
−
|
Schaff
|
2007
|
41
|
Sensate free osteofasciocutaneous
|
3
|
Vaginal flap, labia minora, or metoidioplasty
|
Sensate free osteofasciocutaneous fibular flap
|
Vaginal epithelium or full-thickness skin graft (n = 29, n not stratified between RFF and fibula)
|
−
|
Schaff and Papadopulos
|
2009
|
31
|
Sensate free osteocutaneous
|
3
|
Anterior vaginal flap
|
Sensate free osteocutaneous fibular flap
|
Vaginal mucosa
|
−
|
Other flaps
|
Lin and Chen
|
2009
|
1
|
Free thoracodorsal artery perforator
|
3
|
Anterior vaginal flap
|
Medial forearm full-thickness skin graft
|
Vaginal mucosa
|
−
|
Santanelli and Scuderi
|
2000
|
5
|
Tensor fasciae latae island
|
3
|
Skin strip between native urethral meatus to clitoris
|
Subcutaneous island flap from preputial apron
|
Full-thickness skin graft from lateral thigh
|
−
|
Namba et al
|
2019
|
15
|
Various, radial forearm and deep inferior epigastric artery perforator most common
|
1
|
Labia minora (n = 9), vaginal flap (n = 4), or metoidioplasty (n = 2)
|
Various, radial forearm whenever available
|
−
|
−
|
The number of stages varied by flap type. RFFs used anywhere between one and four stages, with the majority of procedures being performed in a single stage[13]
[26]
[27]
[32]
[36] ([Table 2]). The majority of ALT phalloplasties, were completed in a single stage,[13]
[18] but some were performed in two,[41] and others left staging undefined.[30] Phalloplasty with fibular flap was completed in two[20] or three stages,[34]
[35]
[39] with a median of three stages. Abdominal phalloplasties were completed in one,[19] two,[19]
[21]
[41] or three stages.[25] Procedures that used other flaps or a combination of flaps were either completed in one[33] or three stages.[29]
[38]
As is standard for masculinizing phalloplasty, all studies reported completing two steps for urethral lengthening: the creation of the pars fixa, or the portion of the urethra between the native urethra and the base of the phallus, and the creation of the pars pendulans which extends throughout the neophallus. The pars fixa, or proximal urethra, was completed with a variety of different flaps including the anterior vaginal wall,[20]
[24]
[25]
[26]
[28]
[29]
[31]
[32]
[34]
[37]
[39] labia minora,[13]
[25]
[26]
[27]
[30]
[31]
[32]
[33]
[35]
[36]
[37]
[40] vaginal flap,[23]
[33]
[36]
[39] vaginal mucosa,[41] bladder,[21] urethral plate,[36] metoidioplasty,[33]
[35] and vestibular and infundibular skin strips[18]
[19]
[20]
[22]
[38]
[40] ([Table 2]). The pars pendulans, or distal urethra, was typically created with the same flap used to create the body of the phallus, but other options included vaginal graft,[31] a full-thickness skin graft from the median forearm,[29] and subcutaneous island flap from the preputial apron.[38] When prelamination of the pars pendulans was performed, it was typically made with vaginal mucosa,[22]
[23]
[29]
[31]
[35]
[37]
[39]
[41] although usage of buccal mucosa,[37] lower abdominal wall,[40] and split-thickness skin grafts from the thigh[20]
[31]
[34]
[38]
[39] were also reported. Additionally, some studies reported providing reinforcement at the urethral anastomosis between the pars fixa and pars pendulans during urethral lengthening.[13]
[19]
[24]
[26]
[30]
[31]
[37]
[40] Such reinforcement was provided by layers of soft tissue,[26] the labia minora,[31] fasciolipomatous tissue,[30] the Martius fat pad,[19]
[24] vascularized bulbospongiosus tissue,[13] the myofascial gracilis flap,[37] or perineal muscle.[40]
Complications
Urethral stricture and fistula were the most commonly reported complications across studies ([Table 3]). Less frequently reported complications included partial and complete flap loss, wound dehiscence, infection, donor-site morbidity, abscess, and venous or arterial thrombosis. Studies also reported on a variety of factors thought to have affected complication rates within their samples beyond flap type and number of stages. Factors hypothesized to reduce urethral stricture and fistula included procedure standardization,[27] experience levels of the surgical team,[27] prelamination of the pars pendulans,[22]
[31]
[34] vaginectomy,[30] flap rotations and shaping,[24]
[26] and reinforcement of the urethral anastomosis between the native urethra and pars fixa and between the pars fixa and pars pendulans.[37]
[40] Complications and the factors theorized to have impacted them have been qualitatively synthesized in [Table 3], stratified by phallus flap type and number of stages.
Table 3
Complications of phalloplasty for all included studies, sorted by flap type used
Authors
|
Year
|
Sample size
|
Phallus flap subtype
|
No. of stages
|
Urethral fistula [n (%)]
|
Urethral stricture [n (%)]
|
Complete flap loss [n (%)]
|
Other complications [n (%)]
|
Factors identified to impact complications
|
Radial forearm flap (RFF)
|
Ascha et al
|
2018
|
127
|
−
|
1
|
15 (11.8)
|
20 (15.7)
|
−
|
Rectal injury: 1 (0.8)
Hematoma: 5 (3.9)
Abscess: 5 (3.9)
Wound dehiscence: 2 (1.6)
Partial flap loss: 5 (3.9)
Meatus stenosis: 14 (11.0)
|
Anterolateral thigh flap associated with greater odds of urethral fistula, nonurethral complications, and phallus wound dehiscence compared with radial forearm flap
|
Kim et al
|
2010
|
70
|
Osteocutaneous free
|
1
|
21 (30.0)
|
−
|
1 (1.4)
|
−
|
Cylindrical siphon shape connecting pars fixa to pars pendulans associated with lower fistula rates
|
Krueger et al
|
2007
|
253
|
−
|
1
|
24 (9.5)
|
32 (12.6)
|
0
|
Venous thrombosis: 1 (0.3)
Arterial thrombosis: 2 (0.8)
Wound infection: 4 (1.6)
|
Standardization and experience of surgeon explicitly mentioned to reduce complications
|
Monstrey et al
|
2009
|
287
|
−
|
1
|
98 (34.1)
|
47 (16.4)
|
2 (0.7)
|
Partial flap necrosis: 21 (7.3)
Partial flap loss: 21 (7.3)
Anastomotic revision: 34 (11.8)
Pulmonary embolism: 3 (1.0)
Donor-site regrafting: 2 (0.7)
Nerve compression: 2 (0.7)
Delayed wound healing: 32 (11.1)
|
−
|
Rohrmann and Jakse
|
2003
|
25
|
−
|
1
|
11 (44.0)
|
10 (40.0)
|
−
|
−
|
Urethral plate technique of urethral lengthening may lower fistula and stricture rates
|
Fang et al
|
1994
|
56
|
Sensate free
|
2
|
38 (67.9)
|
7 (12.5)
|
1 (1.8)
|
Urethrolithiasis: 2 (3.6)
Hair growth in urethra: 4 (7.1)
Infection: 7 (12.5)
Partial flap loss: 6 (10.7)
|
Prelamination with vaginal mucosa associated with fewer complications and lower fistula rate at anastomosis between pars fixa and pars pendulans
|
Leriche et al
|
2008
|
56
|
Fasciocutaneous
|
2
|
15 (26.8)
|
3 (5.4)
|
3 (5.4)
|
Partial flap necrosis: 2 (3.6)
|
Implantation of penile prosthesis associated with increased complications
|
Medina et al
|
2018
|
6
|
−
|
2
|
2 (33.3)
|
1 (16.7)
|
−
|
−
|
Use of vaginal epithelium for prelamination associated with lower urologic complications
|
Salgado et al
|
2016
|
15
|
−
|
2
|
7 (46.7)
|
−
|
−
|
−
|
Gracilis flap used to cover urethral anastomosis associated with lower urologic complications
|
Song et al
|
2011
|
19
|
−
|
2
|
10 (52.6)
|
14 (73.7)
|
2 (10.5)
|
Cellulitis: 3 (15.8)
Partial skin necrosis: 2 (10.5)
Partial flap loss: 1 (5.3)
|
Urethral reinforcement with perineal muscle and repair prior to anastomosis reduces stricture and fistula
|
Fang et al
|
1999
|
22
|
Osteocutaneous free
|
3
|
14 (63.6)
|
3 (13.6)
|
0
|
Donor-site morbidity: 10 (45.5)
Partial flap loss: 1 (4.5)
|
−
|
Schaff
|
2007
|
25
|
Sensate free
|
3
|
4 (16.0)
|
5 (20.0)
|
0
|
Partial flap necrosis: 1 (4.0)
Partial flap loss: 1 (4.0)
|
−
|
Garaffa et al
|
2010
|
115
|
Radial artery free
|
4
|
20 (17.4)
|
9 (7.8)
|
3 (2.6)
|
Partial skin necrosis: 12 (10.4)
Meatus stenosis: 9 (7.8)
|
A rotation of the anterior vaginal flap to be included in the dorsal aspect of the urethra can reduce urethral fistula by up to 75%
|
Anterolateral thigh (ALT) flap
|
van der Sluis et al
|
2016
|
19
|
Pedicled
|
1
|
2 (10.5)
|
9 (47.4)
|
3 (15.8) (2 RFF, 1 ALT)
|
Donor-site infection: 1 (5.3)
Partial flap loss: 1 (5.3)
|
Radial forearm flap failures partially attributed to outer flap complications affected vascularization of inside flap
|
Ascha et al
|
2018
|
59
|
Pedicled
|
1
|
12 (20.3)
|
13 (22.0)
|
−
|
Hematoma: 1 (1.7)
Abscess: 1 (1.7)
Meatus stenosis: 2 (3.4)
Partial flap loss: 5 (8.5)
Wound dehiscence: 6 (10.1)
|
Anterolateral thigh flap associated with greater odds of urethral fistula, nonurethral complications, and phallus wound dehiscence compared with radial forearm flap
|
Abdominal flap
|
Bettocchi et al
|
2005
|
32
|
Suprapubic
|
1
|
30 (93.8)
|
30 (93.8)
|
3 (4.6)^
|
Urethral stones: 2 (6.3)
Meatus stenosis: 10 (31.3)
|
Urethral fistula and stricture reduced in two-stage procedures
|
Bettocchi et al
|
2005
|
33
|
Suprapubic
|
2
|
15 (45.5)
|
21 (63.6)
|
3 (4.6)^
|
Urethral stones: 3 (9.1)
Meatus stenosis: 12 (36.4)
|
Urethral fistula and stricture reduced in two-stage procedures
|
Edgerton et al
|
1984
|
1
|
Midline bipedicle
|
2
|
−
|
−
|
0
|
−
|
Postoperative course described as completely uneventful
|
Hage et al
|
1993
|
25
|
Abdominal skin (n = 16), rectus abdominis myocutaneous (n = 7), groin skin (n = 2)
|
3
|
3 (12.0)
|
2 (8.0)
|
0
|
Wound dehiscence: 6 (24.0)
|
−
|
Fibular flap
|
Dabernig et al
|
2006
|
5
|
Sensate free septocutaneous
|
2
|
−
|
2 (40.0)
|
0
|
Meatus stenosis: 1 (20.0)
|
−
|
Papadopulos et al
|
2008
|
32
|
Sensate free osteocutaneous
|
3
|
7 (21.9)
|
10 (31.3)
|
2 (6.3)
|
Infection: 2 (6.3)
Partial flap loss: 4 (12.5)
Wound dehiscence: 4 (12.5)
|
Prelamination of pars pendulans with split-thickness skin graft reduces urethral fistula
|
Schaff
|
2007
|
41
|
Sensate free osteofasciocutaneous
|
3
|
5 (12.2)
|
6 (14.6)
|
2 (4.9)
|
Partial flap necrosis: 5 (12.2)
Partial flap loss: 5 (12.2)
|
−
|
Other flaps
|
Lin and Chen
|
2009
|
1
|
Free thoracodorsal artery perforator
|
3
|
−
|
−
|
0
|
−
|
Postoperative course described as completely uneventful
|
Santanelli and Scuderi
|
2000
|
5
|
Tensor fasciae latae island
|
3
|
3 (60.0)
|
1 (20.0)
|
−
|
Partial flap necrosis: 1 (20.0)
Partial flap loss: 1 (20.0)
|
−
|
Complications not stratified by flap type
|
Schaff and Papadopulos
|
2009
|
37
|
Sensate free radial forearm (n = 6), sensate free osteocutaneous fibular flap (n = 31)
|
3
|
6 (16.2)
|
12 (32.4)
|
−
|
Partial flap necrosis: 6 (16.2)
Partial flap loss: 6 (16.2)
|
−
|
Massie et al
|
2017
|
224
|
Radial forearm (n = 155), Pedicled anterolateral thigh (n = 67)
|
−
|
35 (15.6)
|
40 (17.9)
|
−
|
Hematoma: 6 (2.7)
Abscess: 8 (3.6)
Rectal injury: 1 (0.4)
Scrotal complication: 1 (0.4)
Wound dehiscence: 9 (4.0)
Partial flap loss: 10 (4.5)
Meatus stenosis: 19 (8.5)
|
Vaginectomy associated with decrease in urethral fistula and stricture
|
Zhang et al
|
2015
|
22
|
Pedicled anterolateral thigh (n = 8), abdominal flap (n = 14)
|
2
|
7 (31.8)
|
1 (4.5)
|
0
|
−
|
−
|
Namba et al
|
2019
|
15
|
Various, radial forearm and deep inferior epigastric artery perforator most common
|
1
|
5 (33.3)
|
−
|
0
|
Venous thrombosis: 3 (20.0)
Urethral calculus: 2 (13.3)
Arterial thrombosis: 1 (6.7)
Rod infection: 1 (6.7)
Partial flap loss: 1 (6.7)
|
−
|
Note: ^This number was not stratified by stage, and reflects the complete flap loss for both 1- and 2-stage procedures (i.e. full study sample).
Across all studies, rates of reported fistula formation ranged anywhere from none to 93.8%. Fistula rates for the RFF ranged from 9.5 and 67.9%, with most estimates falling between 15 and 35% ([Table 3]). Phalloplasty with the ALT flap reported fistula formation in 10.5 to 20.3% of cases, while ranges of reported fistula rates for abdominal phalloplasty were between none and 93.8% of cases. Fibular flap phalloplasty had the lowest number of reported fistulae, ranging from none to 21.9% of patients.
Urethral strictures were frequently reported across all studies, occurring in anywhere between 0 and 93.8% of phalloplasty procedures completed with transgender men ([Table 3]). Average rates of stricture varied widely by study and by flap type utilized. Urethral stricture occurred in 9.5 to 67.9% of RFF, 22.0 to 47.4% of ALT, 0 to 93.8% of abdominal flap, and 14.6 to 40.0% of fibular flap phalloplasties, respectively ([Table 3]).
Complete flap loss was less frequently reported as having occurred across studies compared with urethral fistula or stricture, occurring in between 0 and 15.8% of phalloplasties performed ([Table 3]). Notably, in contrast to other complications, such as wound dehiscence and partial flap loss, complete flap loss was explicitly mentioned to have not occurred in the majority of included studies where it was included. Similarly to urethral fistula and stricture, rates of complete flap loss varied widely between studies and flap types. Where reported, complete flap loss occurred in between 0 and 10.5% of RFF, 15.8% of ALT patients, between 0 and 4.6% of abdominal flaps, and 0 and 6.3% of fibular phalloplasty patients, respectively.
Discussion
To our knowledge, this is the first systematic review to assess whether flap choice and number of stages affect complication rates of masculinizing phalloplasty in transgender men. Unfortunately, the low to very low quality of evidence and moderate to high risk of bias of the included studies raises concerns that the extracted data may not reflect true population values, which makes it challenging to draw firm conclusions about the effects of any factors on complications of phalloplasty. Additionally, most complications other than fistulae, strictures, and complete flap loss were inconsistently reported in the literature, which limited the researchers' ability to perform rigorous analyses examining the effects of staging and flap type on complications such as donor-site morbidity or flap necrosis. Notably, information about complete flap loss was only included in 72% of studies compared with 88 and 96% of studies for urethral stricture and fistula, respectively.
The high level of heterogeneity in our extracted data, both within groupings by flap and in the total included study population, suggests that factors beyond the scope of this review, such as surgical expertise[27] and follow-up care protocols,[42] may have influenced the results of the reported studies. It is plausible that the variations in complication rates are due to a combination of small sample sizes and unmeasured factors such as differences in technique. As evidenced by [Table 3], there are several factors that have been theorized to affect the outcomes of phalloplasty but none have been rigorously evaluated. One such factor potentially affecting complications may be the technique used for neourethral construction, which varies greatly between surgeons. Such variations may include flaps used for proximal and distal urethral lengthening, inclusion of prelamination, and choice of prelamination graft, several of which were reported by included studies as affecting intrapopulation outcomes.[22]
[31]
[34]
[37]
[40] As these techniques are not standardized and may be used with multiple flap types and staging, it is difficult to clearly assess their impact. Postoperative care protocols, which were not consistently reported, may have also impacted complication rates.
It is also possible that any reported differences between study types may be a result of reporting and publication bias. Several of the included studies report the development of new techniques, thus may have been subject to publication bias as publishers are more likely to publish a novel surgical technique with favorable results.[43] Further literature with more robust data are required to facilitate a comparison of surgical technique for masculinizing phalloplasty and should include other factors theorized to impact complications but were rarely reported across studies such as follow-up care protocols, patient comorbidities, and surgical expertise.
Conclusion
Phalloplasty is a relatively young procedure with few standardized techniques, leading to poor quality data with inconsistent reporting of technique, outcomes, and confounding factors. Due to the limited number of surgeons across the globe who perform masculinizing gender-affirming surgeries and the relatively short history of these procedures, it is a challenge to draw firm conclusions from the available data. As the field evolves, it is critical to develop a standardized set of reporting parameters to allow for rigorous comparison between studies as well as further investigation into both patient and procedural factors that may affect surgical outcomes. The use of this reporting framework and standardized data will help clinicians and patients alike by providing high-quality evidence. We believe that such a set of guidelines is essential to creating a solid evidence base with which to guide patient care decision making. As there is currently insufficient evidence to identify an ideal surgical technique, the choice of phallus flap(s) and number of surgical stages should depend on factors such as surgeon and patient preference, resources, anesthetic safety, and patient tolerance.